Does Surgeon (Instead of Operator) Experience Affect TAVR?

There is a correlation between the volume of conventional surgical aortic valve replacement procedures and better outcomes in transcatheter aortic valve replacement (TAVR), with higher 30-day and 1-year mortality in sites with lower volume. This is a probable indication that a good surgical team is complemented by a good hemodynamic team and, ultimately, a good heart team that carefully selects which patients will be assigned to each strategy.

Experiencia de los cirujanos

Additionally, there is much evidence indicating that interventional cardiologist experience has a significant impact on outcomes. This work solidifies our understanding that the whole team’s experience (and not only individual operator experience) is important.

Researchers assessed 208,400 patients who underwent heart surgery from 2012 to 2015. Sites were classified according to the volume of surgeries during the study period. The primary endpoint was mortality at 30 days and at 1 year after TAVR.

A total of 65,757 patients underwent surgical valve replacement and 42,967 underwent TAVR. Among TAVR procedures, 21.7% (n = 9324) were performed at hospitals with <100 surgeries per year, 35.6% at sites with 100 to 199 surgeries, 22.9% at sites with 200 to 299, and 19.8% at hospitals with over 300 surgical aortic valve replacement procedures per year.


Read also: ACC 2020 Virtual | PRECOMBAT: 10 años para cirugía vs angioplastia en el tronco de la coronaria izquierda.


Mortality at 30 days was 30% higher in sites with <100 surgeries and 25% in sites with 100 to 199 surgeries, compared with sites with >300 surgeries (odds ratio [OR]: 1.32; 95% confidence interval [CI]: 1.18 to 1.47, and OR: 1.25; 95% CI: 1.12 to 1.39, respectively). The difference in relation to sites with 200 to 299 surgeries was not significant.

The aforementioned differences persisted one year after TAVR.

Conclusion

The total volume of surgical aortic valve replacement procedures at a site is well correlated with TAVR outcomes for the same site. Sites with <100 surgeries per year have the highest mortality rate with TAVR. These data support the notion that surgical programs go hand in hand with TAVR programs, and that a minimum of surgical procedures should be considered as an additional metric for TAVR outcomes.

Original title: Relationship Between Hospital Surgical Aortic Valve Replacement Volume and Transcatheter Aortic Valve Replacement Outcomes.

Reference: Sameer A. Hirji et al. J Am Coll Cardiol Intv 2020;13:335–43.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...